Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 5/2016

27.01.2016 | Original Article – Cancer Research

Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany

verfasst von: M. Bade, V. Bähr, U. Brandt, A. Eigentopf, T. Brüchert, M.-L. Gross, E. Motsch, N. Becker

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

In the German lung cancer screening trial LUSI, smoking cessation counseling (SCC) was offered to all participants at time of randomization, and smoking habits were asked for within annual questionnaire inquiries. We analyzed the smoking habits of the participants within the first 2 years of follow-up and especially the potential effect of the SCC on these habits.

Materials and methods

We used the smoking data of the initial inquiry on which the decision on invitation to the study was based, the socio-economic data of the questionnaire filled-in at time of randomization, the psycho-social data obtained during the SCC, and the annual questionnaire data of the first two annual follow-up screening rounds.

Results

Smoking prevalence decreased in the entire cohort significantly by 4 %, whereby the decrease was with 4.5 % statistically not significantly higher in the control arm than in the screening arm with 3.4 %. The decline was much stronger in the subgroup of attendees to stop-smoking counseling and mounted up therein to 10 %. In some participants, an increase of readiness to quit smoking was observed during the counseling hour, but did not show effects on smoking status 2 years later.

Discussion

We did not see a tendency to increased smoking among participants of the intervention arm or the entire study. The decline of smoking prevalence among the attendees of the counseling might be due to self-selection. Since the issue of effectiveness of smoking cessation counseling is important, further research with randomization into offering counseling or no intervention should be taken into consideration.
Literatur
Zurück zum Zitat Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M (2009) Effect of CT screening on smoking habits at 1 year follow-up in the Danish lung cancer screening trial (DLCST). Thorax 64:388–392. doi:10.1136/thx.2008.102475 CrossRefPubMed Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M (2009) Effect of CT screening on smoking habits at 1 year follow-up in the Danish lung cancer screening trial (DLCST). Thorax 64:388–392. doi:10.​1136/​thx.​2008.​102475 CrossRefPubMed
Zurück zum Zitat Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 12:159–182CrossRefPubMed Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 12:159–182CrossRefPubMed
Zurück zum Zitat Flehinger BJ, Kimmel M, Melamed MR (1992) The effect of surgical treatment on survival from early lung cancer. Implic Screen Chest 101:1013–1018PubMed Flehinger BJ, Kimmel M, Melamed MR (1992) The effect of surgical treatment on survival from early lung cancer. Implic Screen Chest 101:1013–1018PubMed
Zurück zum Zitat Lindinger P (2000) Die Rauchersprechstunde: Beratungskonzept für Gesundheitsberufe, vol 1. Rote Reihe Tabakprävention und Tabakkontrolle, Heidelberg Lindinger P (2000) Die Rauchersprechstunde: Beratungskonzept für Gesundheitsberufe, vol 1. Rote Reihe Tabakprävention und Tabakkontrolle, Heidelberg
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
Zurück zum Zitat Parsons LS (2004) Performing a 1: N case-control match on propensity score. In: Proceedings of the 29th annual SAS users group international conference. SUGI 29, SAS Institute Inc, Montreal, pp 165–29 Parsons LS (2004) Performing a 1: N case-control match on propensity score. In: Proceedings of the 29th annual SAS users group international conference. SUGI 29, SAS Institute Inc, Montreal, pp 165–29
Zurück zum Zitat Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking. Toward an integrative model of change. J Consult Clin Psychol 51:390–395CrossRefPubMed Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking. Toward an integrative model of change. J Consult Clin Psychol 51:390–395CrossRefPubMed
Zurück zum Zitat Ratitch B, Lipkovich I, O’Kelly M (2013) Combining analysis results from multiply imputed categorical data. In: PharmaSUG2013-Paper SP03. SAS Institute Inc Ratitch B, Lipkovich I, O’Kelly M (2013) Combining analysis results from multiply imputed categorical data. In: PharmaSUG2013-Paper SP03. SAS Institute Inc
Zurück zum Zitat Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL (2009) Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomark Prev 18:3484–3489. doi:10.1158/1055-9965.EPI-09-0895 CrossRef Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL (2009) Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomark Prev 18:3484–3489. doi:10.​1158/​1055-9965.​EPI-09-0895 CrossRef
Zurück zum Zitat Townsend CO et al (2005) Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 103:2154–2162. doi:10.1002/cncr.21045 CrossRefPubMed Townsend CO et al (2005) Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 103:2154–2162. doi:10.​1002/​cncr.​21045 CrossRefPubMed
Zurück zum Zitat van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65:600–605. doi:10.1136/thx.2009.133751 CrossRefPubMed van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65:600–605. doi:10.​1136/​thx.​2009.​133751 CrossRefPubMed
Metadaten
Titel
Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany
verfasst von
M. Bade
V. Bähr
U. Brandt
A. Eigentopf
T. Brüchert
M.-L. Gross
E. Motsch
N. Becker
Publikationsdatum
27.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 5/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2105-0

Weitere Artikel der Ausgabe 5/2016

Journal of Cancer Research and Clinical Oncology 5/2016 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.